Amn Healthcare Services Inc. (AMN)
AMN Healthcare: Signs Of Normalization
In Q4 2024 AMN Healthcare posted meaningful sequential revenue growth for the first time in 2 years, suggesting its cyclical decline might be coming to an end. A variety of indicators shows stabilisation in the market, but an upward inflection doesn't seem imminent. Long-term growth and margin drivers like platformization and a larger tech segment are intact, but acquisitions are on hold due to high debt.
New Strong Sell Stocks for February 25th
AMN, CABGY and BNPQY have been added to the Zacks Rank #5 (Strong Sell) List on February 25, 2025.
AMN Stock Gains Following Q4 Earnings & Revenues Beat, Margins Down
AMN Healthcare's dismal results in the majority of its segments led to a soft overall fourth-quarter performance.
AMN Healthcare Services, Inc. (AMN) Q4 2024 Earnings Call Transcript
AMN Healthcare Services, Inc. (NYSE:AMN ) Q4 2024 Earnings Conference Call February 20, 2025 5:00 PM ET Company Participants Randall Reese - Senior Director of Investor Relations and Strategy Cary Grace - President and Chief Executive Officer Brian Scott - Chief Financial Officer and Chief Operating Officer Conference Call Participants Jasper Bibb - Truist Securities, Inc. A.J. Rice - UBS Investment Bank Jeffrey Silber - BMO Capital Markets Joanna Gajuk - Bank of America Merrill Lynch Mark Marcon - Robert W.
Compared to Estimates, AMN Healthcare (AMN) Q4 Earnings: A Look at Key Metrics
Although the revenue and EPS for AMN Healthcare (AMN) give a sense of how its business performed in the quarter ended December 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
AMN Healthcare Services (AMN) Q4 Earnings and Revenues Top Estimates
AMN Healthcare Services (AMN) came out with quarterly earnings of $0.75 per share, beating the Zacks Consensus Estimate of $0.52 per share. This compares to earnings of $1.32 per share a year ago.
What to Expect From These 3 MedTech Stocks This Earnings Season?
Here is a sneak peek into how three MedTech stocks, GKOS, ITGR and AMN, are expected to fare in their quarterly results, slated to be released tomorrow.
Insights Into AMN Healthcare (AMN) Q4: Wall Street Projections for Key Metrics
Looking beyond Wall Street's top -and-bottom-line estimate forecasts for AMN Healthcare (AMN), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the quarter ended December 2024.
Bear of the Day: AMN Healthcare Services (AMN)
Shares have tumbled to new 5-year lows.
AMN Healthcare: Stock Repurchases, Tech Solutions, Significantly Undervalued
AMN Healthcare Services offers innovative staffing solutions like ShiftWise Flex and AMN Passport, enhancing efficiency and providing tools hospitals and clinics can't develop in-house. Despite recent revenue declines, AMN's historical profitability, positive cash flow, and strategic stock repurchases indicate a strong business model and potential undervaluation. Anticipated EPS growth, potential tax reductions, and continued technological advancements suggest significant upside, with fair value estimates around $42-$43 per share.
AMN Healthcare: In Buyable Territory
The Nurse & Allied sales declines are acute and material, but will eventually stop and grow over time. The market, however, seems to be pricing in extremely severe declines ahead. Coupled with that reality is an under-the-radar, growing Language services business the market appears to be missing. While capital allocation is a risk, AMN's price presents an intriguing risk/reward as I believe the market's pricing in more declines than economically likely with near-term data points corroborating this.
Bear of the Day: AMN Healthcare Services (AMN)
There's no bottom yet in medical staffing.
